MASHINIi

IM Cannabis Corp..

IMCC.US | Wholesale of food, beverages and tobacco

IM Cannabis Corp. (IMCC) is a multi-country operator (MCO) in the cannabis sector with operations primarily in Israel, Canada, and Germany. The company cultivates, processes, and distributes medical and recreational cannabis products. IM Cannabis focuses on premium and indoor-grown cannabis. They ar...Show More

Ethical Profile

Mixed.

IM Cannabis Corp. (IMCC.US) has faced product safety concerns, including a recall of nine cannabis products in New York due to alleged pesticide contamination, though no adverse effects were reported. The company has also been linked to non-compliance with Nasdaq listing requirements, specifically regarding minimum stockholders' equity. Critics point to loan agreements with shareholders at high interest rates, such as 18%, which could raise conflict-of-interest concerns. In terms of governance, IM Cannabis maintains a Code of Business Conduct and Ethics, featuring a whistleblower policy with reporting mechanisms and explicit prohibitions against bribery and kickbacks.

Value Scores

Better Health for All-40
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals0
-100100
No War, No Weapons-10
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities-60
-100100
Safe & Smart Tech-70
-100100
Zero Waste & Sustainable Products-40
-100100

Better Health for All

-40

Nine cannabis products from IndoGrow LLC were recalled on June 12, 2025, due to positive pesticide tests.

1
No adverse effects have been reported in connection with these recalled products.
2

Fair Money & Economic Opportunity

0

IM Cannabis Corp. operates in the cannabis sector, focusing on cultivation, processing, and distribution of medical and recreational cannabis products.

1
The provided articles detail the company's financial performance, regulatory actions, and corporate restructuring. There is no evidence in the articles to suggest that IM Cannabis Corp. offers lending, deposit, or other financial services to consumers, nor does it engage in activities related to financial inclusion or economic opportunity for underserved populations. Therefore, all KPIs under the 'Fair Money & Economic Opportunity' value are not applicable to the company's business model as described.

Fair Pay & Worker Respect

0

No evidence available to assess IM Cannabis Corp. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No evidence available to assess IM Cannabis Corp. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

-40

IM Cannabis Corp. has a formal whistleblower policy, implemented on November 26, 2020.

1
This policy includes detailed procedures for reporting questionable accounting, auditing, or securities law violations, offering anonymous reporting options via an ethics hotline, General Counsel, or the Audit Committee Chair, with an emphasis on non-retaliation.
2
However, there is no explicit evidence regarding the independence of investigation processes. The company also has an anti-corruption policy, established on the same date, which explicitly prohibits bribery and kickbacks and provides guidance on facilitating payments, indicating FCPA compliance.
3
While the policy is in place, there is no information on the frequency or effectiveness metrics of anti-corruption training.

Kind to Animals

0

No evidence was found in the provided articles to assess IM Cannabis Corp. against the 'Kind to Animals' ethical value. The articles primarily discuss financial and corporate matters such as auditor changes, delisting from an exchange, and Nasdaq compliance issues. One article mentions an investment in a company focused on cannabinoid-based APIs using plant genetics and metabolomics, but it does not provide specific data on animal-free technologies, animal testing policies, or ethical sourcing percentages relevant to the rubric's KPIs.

1
General articles about veganic cannabis or fertilizers also do not contain company-specific, scorable data.

No War, No Weapons

-10

IM Cannabis Corp. is a cannabis company with no reported involvement in defense or arms-related activities, resulting in N/A scores for most KPIs.

1
The company has a 'Forced Labour and Child Labour Report' and a 'Code of Business Conduct and Code of Ethics' available,
2
and mentions setting due diligence standards based on global guidance like the OECD,
3
indicating support for UN Guiding Principles in principle, but implementation details are uneven. While the company focuses on responsible mineral sourcing to avoid human rights risks, there is no specific evidence of adherence to humanitarian procurement standards.
4
The company needs to monitor and plan for regulatory updates and sanctioned party lists, and review data for red flags, but there is no evidence of an annual review process for partners with conflict-related risks.
5
The company uses 3TGs and other high-risk minerals, but no specific percentage of its supply chain is certified conflict-free.
6

Planet-Friendly Business

0

No specific, concrete data points were found in the provided articles for any of the Planet-Friendly Business KPIs. The articles discuss general challenges in the cannabis industry regarding ESG integration and water use, and IMCC.US's financial and listing compliance issues, but do not provide quantitative environmental performance metrics, targets, or initiatives for the company.

Respect for Cultures & Communities

-60

The company experienced one cultural appropriation incident, the 'La Chingona' case, involving the use of Spanish-language taglines and product names without apparent engagement with the Latinx community.

1
Following public pressure and a boycott, dispensaries canceled orders, indicating a loss of social license to operate.
2
The company issued a public apology on La Chingona's Instagram page, which constitutes a reactive response after public pressure.
3
Demands were made for the company to donate $300,000, representing total sales from the product, or remaining profits to cultural heritage organizations, but there is no evidence that this donation was made.
4
The use of Spanish-language product names and taglines without community engagement suggests limited local language incorporation.
5

Safe & Smart Tech

-70

IMCC.US experienced a significant data breach in July 2025, exposing 957,434 sensitive patient records, including Social Security numbers, driver's license images, medical records, and over 210,000 email addresses.

1
This data, totaling 300-323 GB, was unencrypted and lacked password protection.
2
The company restricted database access within one day of being alerted after a security researcher discovered the unsecured database.
3
Multiple federal lawsuits have been filed alleging negligence in safeguarding this information, and the State Medical Board of Ohio is investigating.
4
The company's website indicates it gathers broad demographic information using IP addresses and saves passwords via cookies.
5
A subsidiary, Adjupharm GmbH, is EU-GMP certified, but this is not a privacy or security certification for the entire company's data handling.
6

Zero Waste & Sustainable Products

-40

IM Cannabis Corp. utilizes GAIACA for the compliant disposal of hazardous waste, including flammable solvents, flammable solids, and aqueous corrosives.

1
This involves transporting waste to a Treatment, Storage, and Disposal Facility (TSDF) for final disposal and documenting services via Uniform Hazardous Waste Manifests.
2
The company receives assistance with DTSC, EPA, and CUPA registration and reporting, and in obtaining an EPA Identification Number.
3
There have been no waste disposal violations reported for IM Cannabis Corp. in the past three years.
4
Allegations regarding inadequate construction permitting at its Focus facility in December 2020 and January 2021 were not related to waste disposal.
5

Own IM Cannabis Corp.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.